CD4+ T TILs recruitment in tumors often follows a regulatory T cell (Treg) subset, which leads to severe immunodeficiency and can be produced by TAMs through cytokine expression, as reported in ovarian cancer patients [33]. The gene discussed is CD4; the disease is immune system disorder.